Am I too late to buy MRSH?

Marsh & McLennan Companies, Inc. (MRSH): Yes, too late. We wouldn't buy it here.

Verdict as of .

Our model puts the odds of MRSH being higher in three months at 2% (worse than a coin flip), and its three-month estimate is $176.04, 6.3% below today's $187.84. Buying now means paying more than we think it will be worth, so we wouldn't start a position at this price: a missed trade costs nothing, this one can.

Where we'd be wrong: We're wrong if MRSH closes above $186.86 within three months, the top of our 90% forecast band. Above that our model under-called the move: our call failed, and we withdraw it.

The prices behind this verdict

Why: the risk checks behind the call

Related pages:

Educational research only — not investment advice.